SS
AKRO

SBI Securities’s Akero Therapeutics AKRO Stock Holding History

SBI Securities’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19
Closed -$902 – 4019
2025
Q3 		$902 Buy
19
+17
+850% +$823 ﹤0.01% 2737
2025
Q2 		$107 Hold
2
– – ﹤0.01% 3517
2025
Q1 		$81 Hold
2
– – ﹤0.01% 3510
2024
Q4 		$56 Buy
+2
New +$61 ﹤0.01% 3612

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SBI Securities's AKRO Position: Q4 2025 in Review

SBI Securities sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 19 shares — an estimated $902 sold.

SBI Securities first reported a position in AKRO in Q4 2024 and held it in 4 quarters. The position peaked at $902 in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • SBI Securities reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • SBI Securities sold 19 Akero Therapeutics shares in Q4 2025, an estimated $902.
  • SBI Securities first reported a position in Akero Therapeutics in Q4 2024 and held it in 4 quarters.
  • SBI Securities's Akero Therapeutics position peaked at $902 in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.